This site is part of the Siconnects Division of Sciinov Group
This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
Peter Mathiesen is the Managing Partner at Iduna Capital, a venture capital rm focused on early-stage longevity-biotech investments. He supports transformative solutions that redene how we age and how to extend healthspan.
Peter also runs Join Longevity, a newsletter that raises awareness about longevity science and inspires public engagement with the eld. Through actively sharing industry news and insights, as well as investing in breakthrough technologies, he addresses two major challenges in longevity awareness and funding.
With a Master’s degree in Innovation and Entrepreneurship in Biomedical Engineering from the University of Barcelona, Peter has led projects in aging-biomarker diagnostics and bacteriophage therapies.
Peter’s mission is to accelerate the development of technologies that redene aging, creating a future where longer, healthier lives are possible for everyone.